PAVBLU sol inj 2mg/0.05ml ser pré

7680697630013 CH-69763 S01LA05 11.99.0.
PAVBLU sol inj 2mg/0.05ml ser pré
PAVBLU sol inj 2mg/0.05ml ser pré
PAVBLU sol inj 2mg/0.05ml ser pré
1 / 3
google

Details

Product number
6976301
CPT
-
Packaging group
1
Unit
Spritze(n)
Composition
afliberceptum 2 mg, saccharum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 0.05 ml.

Articles (1)

Pavblu 40 mg/ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
69763
Drug name
Pavblu, Injektionslösung in einer Fertigspritze
Galenic form
LSINJ
ATC Code
S01LA05
Authorization status
Z
Dispensation category
B
First authorization
17/06/2025
Authorization expiration date
16/06/2030
IT number
11.99.0.
Domain
Human medicine
Field of application
Exsudative (feuchte) altersbezogene Makuladegeneration (AMD). Makulaödem infolge eines retinalen Zentralvenenverschlusses (CRVO) und retinalen Venenastverschlusses (BRVO), diabetisches Makulaödem (DME), Behandlung von subfovealen und juxtafovealen choroidalen Neovaskularisationen infolge einer pathologischen Myopie (mCNV).

Packaging details

Description (FR)
PAVBLU sol inj 2mg/0.05ml ser pré
Description (DE)
PAVBLU Inj Lös 2mg/0.05ml Fertspr
Market launch
01/12/2025
Narcotic (BTM)
No